Zhonghong Pulin Medical Products Co. Ltd. Net Assets
Zhonghong Pulin Medical Products Co. Ltd. net assets. Based on the latest financial reports, Zhonghong Pulin Medical Products Co. Ltd. (300981) has net assets worth CN¥5.42 Billion CNY (≈ $792.81 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥7.69 Billion ≈ $1.13 Billion USD) and total liabilities (CN¥2.27 Billion ≈ $332.22 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how fast is Zhonghong Pulin Medical Products Co. Ltd growing its equity to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥5.42 Billion |
| % of Total Assets | 70.47% |
| Annual Growth Rate | 36.86% |
| 5-Year Change | -17.28% |
| 10-Year Change | 2024.08% |
| Growth Volatility | 123.5 |
Net Assets of Zhonghong Pulin Medical Products Co. Ltd. (2013–2025)
Net assets of Zhonghong Pulin Medical Products Co. Ltd. from 2013 to 2025. This chart illustrates how Zhonghong Pulin Medical Products Co. Ltd.'s net assets have evolved over time, based on quarterly financial data. See debt-free asset ratio of Zhonghong Pulin Medical Products Co. Ltd to measure how much of total assets are equity-financed.
Annual Net Assets for Zhonghong Pulin Medical Products Co. Ltd. (2013–2025)
The table below shows the annual net assets of Zhonghong Pulin Medical Products Co. Ltd. from 2013 to 2025. For live market cap and overall valuation, see market cap of Zhonghong Pulin Medical Products Co. Ltd.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥5.42 Billion ≈ $793.36 Million |
-3.54% |
| 2024-12-31 | CN¥5.62 Billion ≈ $822.48 Million |
-4.98% |
| 2023-12-31 | CN¥5.92 Billion ≈ $865.55 Million |
-3.55% |
| 2022-12-31 | CN¥6.13 Billion ≈ $897.39 Million |
-6.43% |
| 2021-12-31 | CN¥6.55 Billion ≈ $959.08 Million |
+156.45% |
| 2020-12-31 | CN¥2.56 Billion ≈ $373.98 Million |
+446.49% |
| 2019-12-31 | CN¥467.67 Million ≈ $68.43 Million |
+24.35% |
| 2018-12-31 | CN¥376.10 Million ≈ $55.03 Million |
+17.57% |
| 2017-12-31 | CN¥319.89 Million ≈ $46.81 Million |
+25.32% |
| 2016-12-31 | CN¥255.25 Million ≈ $37.35 Million |
+33.30% |
| 2015-12-31 | CN¥191.49 Million ≈ $28.02 Million |
+26.54% |
| 2014-12-31 | CN¥151.32 Million ≈ $22.14 Million |
+20.55% |
| 2013-12-31 | CN¥125.53 Million ≈ $18.37 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Zhonghong Pulin Medical Products Co. Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 13682.3% over the analyzed period, indicating profitable operations and earnings retention.
Zhonghong Pulin Medical Products Co. Ltd. Net Assets Breakdown (December 2025)
Zhonghong Pulin Medical Products Co. Ltd. net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥3.08 Billion | 58.49% |
| Other Components | CN¥2.18 Billion | 41.51% |
| Total Equity | CN¥5.26 Billion | 100.00% |
Zhonghong Pulin Medical Products Co. Ltd. Competitors by Market Cap
The table below lists competitors of Zhonghong Pulin Medical Products Co. Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
HMC Capital Ltd
AU:HMC
|
$922.57 Million |
|
Finolex Industries Limited
NSE:FINPIPE
|
$922.92 Million |
|
Chengdu Information Technology of Chinese Academy of Sciences Co Ltd
SHE:300678
|
$922.93 Million |
|
Huizhou Speed Wireless Technology Co Ltd
SHE:300322
|
$922.93 Million |
|
Generation Development Group Ltd
AU:GDG
|
$922.47 Million |
|
Beijing Kingee Culture Development Co Ltd
SHE:002721
|
$922.29 Million |
|
Fujian Nanping Sun Cable Co Ltd
SHE:002300
|
$921.71 Million |
|
Intelbras S.A. - Indústria de Telecomunicação Eletrônica Brasileira
SA:INTB3
|
$921.67 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Zhonghong Pulin Medical Products Co. Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 5,474,102,359 to 5,260,709,320, a change of -213,393,039 (-3.9%).
- Net loss of 112,383,173 reduced equity.
- Dividend payments of 126,505,835 reduced retained earnings.
- Other comprehensive income decreased equity by 100,552,861.
- Other factors increased equity by 126,048,831.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-112.38 Million | -2.14% |
| Dividends Paid | CN¥126.51 Million | -2.4% |
| Other Comprehensive Income | CN¥-100.55 Million | -1.91% |
| Other Changes | CN¥126.05 Million | +2.4% |
| Total Change | CN¥- | -3.90% |
Book Value vs Market Value Analysis
This analysis compares Zhonghong Pulin Medical Products Co. Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.20x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 14.00x to 1.20x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | CN¥1.05 | CN¥14.70 | x |
| 2014-12-31 | CN¥3.01 | CN¥14.70 | x |
| 2015-12-31 | CN¥1.51 | CN¥14.70 | x |
| 2016-12-31 | CN¥0.99 | CN¥14.70 | x |
| 2017-12-31 | CN¥1.00 | CN¥14.70 | x |
| 2018-12-31 | CN¥1.17 | CN¥14.70 | x |
| 2019-12-31 | CN¥1.44 | CN¥14.70 | x |
| 2020-12-31 | CN¥7.94 | CN¥14.70 | x |
| 2021-12-31 | CN¥16.67 | CN¥14.70 | x |
| 2022-12-31 | CN¥14.13 | CN¥14.70 | x |
| 2023-12-31 | CN¥13.62 | CN¥14.70 | x |
| 2024-12-31 | CN¥12.57 | CN¥14.70 | x |
| 2025-12-31 | CN¥12.27 | CN¥14.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Zhonghong Pulin Medical Products Co. Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -2.14%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -4.74%
- • Asset Turnover: 0.32x
- • Equity Multiplier: 1.41x
- Recent ROE (-2.14%) is below the historical average (18.86%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 2.44% | 0.55% | 1.11x | 3.97x | CN¥-9.42 Million |
| 2014 | 16.59% | 4.26% | 1.20x | 3.26x | CN¥9.90 Million |
| 2015 | 21.93% | 7.00% | 1.05x | 2.98x | CN¥23.02 Million |
| 2016 | 14.89% | 5.38% | 1.13x | 2.45x | CN¥12.54 Million |
| 2017 | 20.24% | 6.83% | 1.36x | 2.17x | CN¥32.89 Million |
| 2018 | 14.98% | 5.86% | 0.99x | 2.58x | CN¥18.85 Million |
| 2019 | 19.09% | 7.62% | 1.09x | 2.30x | CN¥42.50 Million |
| 2020 | 104.22% | 55.74% | 1.30x | 1.44x | CN¥2.41 Billion |
| 2021 | 35.73% | 47.70% | 0.69x | 1.09x | CN¥1.69 Billion |
| 2022 | 1.09% | 4.26% | 0.23x | 1.11x | CN¥-545.02 Million |
| 2023 | -2.27% | -6.22% | 0.30x | 1.22x | CN¥-707.68 Million |
| 2024 | -1.59% | -3.55% | 0.34x | 1.32x | CN¥-634.54 Million |
| 2025 | -2.14% | -4.74% | 0.32x | 1.41x | CN¥-638.45 Million |
Industry Comparison
This section compares Zhonghong Pulin Medical Products Co. Ltd.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,996,688,898
- Average return on equity (ROE) among peers: 11.74%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Zhonghong Pulin Medical Products Co. Ltd. (300981) | CN¥5.42 Billion | 2.44% | 0.42x | $922.52 Million |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $459.59 Million | 18.46% | 1.95x | $412.17 Million |
| Blue Sail Medical Co Ltd (002382) | $9.55 Billion | -5.95% | 0.64x | $816.83 Million |
| Andon Health Co Ltd (002432) | $1.37 Billion | -12.12% | 0.53x | $3.64 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $2.06 Billion | 15.82% | 0.53x | $782.11 Million |
| Guangzhou Improve Med Instrument (300030) | $592.55 Million | 4.90% | 0.10x | $332.54 Million |
| QITIAN Technology Group Co Ltd (300061) | $64.46 Million | 19.72% | 1.76x | $741.56 Million |
| Shanghai Tofflon Science Tech (300171) | $113.69 Million | 40.44% | 1.35x | $1.49 Billion |
| Truking Technology Ltd (300358) | $2.87 Billion | 6.98% | 1.40x | $927.12 Million |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $1.33 Billion | 15.49% | 0.52x | $724.25 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $1.55 Billion | 13.64% | 0.15x | $1.25 Billion |
About Zhonghong Pulin Medical Products Co. Ltd.
Zhonghong Pulin Medical Products Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of disposable health protection products, sterile medical devices, and life support solutions in China and internationally. It operates through the Health Protection Products Division; Safe Infusion Products Division; and Innovation and Incubation Product Division… Read more